FDA Pursues Consumer Products With Questionable Flu Treatment Claims
This article was originally published in The Tan Sheet
Executive Summary
FDA continues its efforts to protect consumers from the ongoing H1N1 flu outbreak, as well as from opportunistic marketers selling potentially deceptive "cures" for the virus
You may also be interested in...
FDA Top Scientist Goodman Prioritizes "Strengthening Our Scientific Approach"
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original focus: improving the agency's scientific capacity and integrity.
FDA Top Scientist Goodman Prioritizes "Strengthening Our Scientific Approach"
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original focus: improving the agency's scientific capacity and integrity.
FDA Top Scientist Goodman Prioritizes "Strengthening Our Scientific Approach"
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original focus: improving the agency's scientific capacity and integrity.